Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy.

Leopoldo Pérez de IslaEvangelos LiberopoulosMelania DovizioChiara VeronesiLuca Degli EspostiAlberto Zambon

Published in: Advances in therapy (2024)

This real-world analysis suggested that switching from a regimen based on separate pills to one based on a single-pill combination resulted in improved adherence to ROS/EZE therapy.

Keyphrases

stem cells
cell death
dna damage
oxidative stress
adipose tissue
bone marrow
insulin resistance